Eye health issues that are making the news - Autumn 2022.
Caffeine metabolite may slow child myopia progression in children
Short-sightedness was observed to progress more slowly in children taking a compound derived from coffee, according to a new study.
Researchers found that taking 7-methylxanthine (7-MX) – a caffeine metabolite licensed as a myopia treatment in Denmark since 2009 – was associated with smaller increases in axial elongation and refractive error.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
The number of people with glaucoma, AMD and cataracts is set to increase over the next 10 years. This new online tool will be a critical planning resource for commissioners and providers of eye health care.
One thing is certain: I wasn’t expecting the events of the last 10 weeks to take place when I wrote my last Optometry in Practice editorial in February this year.